Video Lectures
State-of-the-industry video lectures by leading urology experts
Latest Videos

SAN DIEGO, CA USA (Press Release) - April 11, 2014 - GenomeDx Biosciences announced today that two study abstracts for the company’s genomic tests for prostate and bladder cancers have been selected as “Best Posters in a Poster Session” by conference organizers at the 29th Annual European Association of Urology Congress.

The first poster presentation demonstrates the clinical validation of the Decipher® prostate cancer classifier for predicting treatment failure in men treated with post-surgery radiation therapy. The second poster presentation reports on the discovery and validation of a 15-marker genomic signature for predicting recurrence in high-risk bladder cancer.

The schedule for the poster presentations at EAU follows:

Session Title: “Improvement in prostate cancer biomarkers measurement”
Abstract Title: “Validation of a genomic classifier for predicting biochemical failure following post-operative radiation therapy in high-risk prostate cancer”
Date and Time: Saturday, April 12, 2014, 4:00 p.m. to 5:30 p.m. UTC
Room: A2
Abstract #: 205

Session Title: “Modern staging of urothelial carcinomas of the bladder and the upper tract: A new era has started”
Abstract Title: “Discovery and validation of a novel expression signature for predicting recurrence in high-risk bladder cancer post-cystectomy”
Date and Time: Monday, April 14, 2014, 12:15 p.m. to 1:45 p.m. UTC
Room: K1
Abstract #:  898

About GenomeDx Biosciences

GenomeDx Biosciences develops and commercializes genomic tests for prostate and other urologic cancers that impact treatment decision-making, improve patient outcomes and ultimately reduce healthcare costs. GenomeDx has developed the Decipher Prostate Cancer Classifier, the first and only commercially available genomic test that predicts the risk of developing metastatic prostate cancer independently of PSA and other conventional risk assessment tools. GenomeDx is based in San Diego, California and Vancouver, British Columbia. www.genomedx.com

### 

GenomeDx Biosciences

[ PRESS RELEASE ] 

 

Calendar
Upcoming urology industry events
July 9-12, 2018 / Tan Tock Seng Hospital
Urology Residents' Course Singapore 2018
July 13-14, 2018 / Manchester Grand Hyatt San Diego
Best of ASCO 2018 - San Diego
Journals
Print publications focusing on urological cancer treatments through original commentary & articles
Everyday Urology Volume 2 Issue 4

Everyday Urology™ - Oncology Insights

From the Editor

PCAN cover

Prostate Cancer and Prostatic Diseases

From the Editor